Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6984403 | PF PRISM CV | Azithromycin dosage forms with reduced side effects |
Feb, 2024
(1 year, 4 days from now) | |
US7887844 | PF PRISM CV | Multiparticulate crystalline drug compositions having controlled release profiles |
Feb, 2024
(1 year, 4 days from now) |
Market Authorisation Date: 10 June, 2005
Treatment: Method of treating bacterial infections
Dosage: FOR SUSPENSION, EXTENDED RELEASE;ORAL
7
United States
2
Poland
2
Japan
2
IB
1
Austria
1
Morocco
1
Hong Kong
1
Korea, Republic of
1
AP
1
Brazil
1
Australia
1
Chile
1
Ukraine
1
Guatemala
1
Dominican Republic
1
Yugoslavia
1
Uruguay
1
Netherlands
1
Spain
1
Germany
1
Israel
1
Cyprus
1
OA
1
Mexico
1
Tunisia
1
Slovenia
1
South Africa
1
Argentina
1
Portugal
1
Georgia
1
Peru
1
EA
1
China
1
Croatia
1
Panama
1
Norway
1
Iceland
1
Canada
1
New Zealand
1
Taiwan, Province of China
1
Denmark
1
Costa Rica
1
Ecuador
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic